InsiderFlow

Mark E. Bunnage

VRTX

Mark E. Bunnage serves as officer: EVP, Chief Scientific Officer at Vertex Pharmaceuticals Incorporated (VRTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$3.54M

Net Position

Net Seller

$3.54M

Companies Traded

1

VRTX

Active Period

Feb 2026 – May 2026

4 total trades

Most Recent

Sell VRTX

May 19, 2026 · $15.0K

Mark E. Bunnage's Insider Trading at Vertex Pharmaceuticals Incorporated (VRTX)

Buys

0 · $0.00

Sells

4 · $3.54M

Total Shares Bought

0

Total Shares Sold

7,403

VRTX Price Chart
Loading chart...
DateTypeValue
May 19, 2026 Sell$15.0K
Feb 26, 2026 Sell$301.5K
Feb 17, 2026 Sell$2.29M
Feb 12, 2026 Sell$930.5K